Health
In Pancreatic Cancer, New Biomarker May Predict Benefit of Tumor-Penetrating Peptide – Genetic Engineering & Biotechnology News
Study of pancreatic cancer identified biomarker that may indicate which patients would respond best to combination therapies incorporating a tumor-penetrating peptide….
Hunkered behind a dense layer of fibrotic tissue, pancreatic tumors stubbornly resist the delivery of therapeutic molecules. Yet this barrier, this desmoplastic tumor tissue, can be penetrated by iRGD, a nine-amino-acid cyclic peptide. In experiments with models of pancreatic cancer, specifically, mouse models and organoids, iRGD was found to penetrate tumors via a molecular pathway mediated by 5 integrin, a protein that is produced by carcinoma-associated fibroblasts (CAFs). This newfound role…
-
Noosa News8 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
General23 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
Noosa News24 hours agoBrisbane widow’s $6 million prize home win comes with unexpected luxury
-
Noosa News8 hours agoFatal traffic crash, Noosa – Sunshine Coast